Valuation Kobayashi Pharmaceutical Co., Ltd. Deutsche Boerse AG
Stocks
KOY
JP3301100008
Personal Products
|
Market Closed -
Deutsche Boerse AG
11:33:07 07/10/2026 am IST
|
After hours 01:28:00 am | |||
| 39.20 EUR | +1.55% |
|
40.20 | +2.55% |
| 25/09 | Kobayashi Pharmaceutical Says No Decision Made on Potential Take-Private Deal by NSSK, CVC Capital Partners | MT |
| 24/09 | Kobayashi Reportedly in ¥500 Billion Buyout Talks After Red-Yeast Case | CI |
Company Valuation: Kobayashi Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,04,427 | 6,50,295 | 5,03,841 | 4,63,131 | 4,03,511 | 5,31,744 | - | - |
| Change | - | -7.68% | -22.52% | -8.08% | -12.87% | 31.78% | - | - |
| Enterprise Value (EV) 1 | 5,96,011 | 5,46,554 | 4,24,992 | 3,98,232 | 3,33,575 | 4,69,331 | 4,61,151 | 4,52,121 |
| Change | - | -8.3% | -22.24% | -6.3% | -16.24% | 40.7% | -1.74% | -1.96% |
| P/E | 35.8x | 34.8x | 25.3x | 46x | 110x | 51x | 39.4x | 32x |
| PBR | 3.59x | 3.47x | 2.47x | 2.18x | 1.92x | 2.54x | 2.45x | 2.37x |
| PEG | - | 12.08x | 7.7x | -0.9x | -1.7x | 0x | 1.3x | 1.4x |
| Capitalization / Revenue | 4.54x | 3.91x | 2.9x | 2.8x | 2.43x | 3.1x | 2.97x | 2.85x |
| EV / Revenue | 3.84x | 3.29x | 2.45x | 2.4x | 2.01x | 2.73x | 2.57x | 2.42x |
| EV / EBITDA | 19.3x | 17.1x | 13.3x | 12.1x | 14.1x | 21.3x | 16.9x | 14.5x |
| EV / EBIT | 22.9x | 20.5x | 16.5x | 16x | 22.4x | 36.8x | 26.4x | 21.1x |
| EV / FCF | 31.8x | 31.1x | -350x | -29.2x | 68.5x | 32.6x | 30.3x | 26.4x |
| FCF Yield | 3.15% | 3.22% | -0.29% | -3.42% | 1.46% | 3.06% | 3.3% | 3.79% |
| Dividend per Share 2 | 83 | 90 | 101 | 102 | 104 | 106 | 109.5 | 114.3 |
| Rate of return | 0.92% | 1% | 1.49% | 1.64% | 1.92% | 1.48% | 1.53% | 1.6% |
| EPS 2 | 252.4 | 259.6 | 268.2 | 135.4 | 49.19 | 140.1 | 181.4 | 223.7 |
| Distribution rate | 32.9% | 34.7% | 37.7% | 75.3% | 211% | 75.6% | 60.4% | 51.1% |
| Net sales 1 | 1,55,252 | 1,66,258 | 1,73,455 | 1,65,600 | 1,65,742 | 1,71,748 | 1,79,252 | 1,86,553 |
| EBITDA 1 | 30,900 | 32,027 | 31,837 | 32,800 | 23,600 | 22,065 | 27,283 | 31,225 |
| EBIT 1 | 26,065 | 26,669 | 25,780 | 24,860 | 14,923 | 12,743 | 17,443 | 21,425 |
| Net income 1 | 19,715 | 20,022 | 20,338 | 10,067 | 3,656 | 10,524 | 13,655 | 16,488 |
| Net Debt 1 | -1,08,416 | -1,03,741 | -78,849 | -64,899 | -69,936 | -62,413 | -70,594 | -79,623 |
| Reference price 2 | 9,040.00 | 9,030.00 | 6,790.00 | 6,230.00 | 5,428.00 | 7,153.00 | 7,153.00 | 7,153.00 |
| Nbr of stocks (in thousands) | 77,923 | 72,015 | 74,203 | 74,339 | 74,339 | 74,339 | - | - |
| Announcement Date | 04/02/22 | 14/02/23 | 09/02/24 | 10/02/25 | 10/02/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.81x | 4.15x | 15.22x | 2.96% | 34TCr | |
| 28.65x | 4.41x | 18.19x | 2.08% | 22TCr | |
| 17.95x | 2.7x | 11.93x | 3.52% | 13TCr | |
| 24.06x | 3.55x | 14.95x | 2.44% | 6.96TCr | |
| 39.35x | 6.33x | 27.47x | 2.38% | 4.62TCr | |
| 51.37x | 7.25x | 27.97x | 0.3% | 4.53TCr | |
| 18.53x | 2.62x | 10.93x | 4.8% | 3.38TCr | |
| 32.09x | 2.43x | 13.53x | 1.67% | 3.38TCr | |
| 14.51x | 2.36x | 10.91x | 5.33% | 3.22TCr | |
| Average | 27.59x | 3.98x | 16.79x | 2.83% | 10.67TCr | |
| Weighted average by Cap. | 25.29x | 4.05x | 16.28x | 2.74% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 4967 Stock
- KOY Stock
- Valuation Kobayashi Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
